ID   TBL.Cl2.Pt
AC   CVCL_D7CH
SY   TBL.Cl2 Pt; TBL.Cl2 PT
RX   PubMed=11378348;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7CG ! TBL.Cl2
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=11378348; DOI=10.1016/s0959-8049(01)00091-0;
RA   Cemazar M., Miklavcic D., Mir L.M., Belehradek J. Jr., Bonnay M.,
RA   Fourcault D., Sersa G.;
RT   "Electrochemotherapy of tumours resistant to cisplatin: a study in a
RT   murine tumour model.";
RL   Eur. J. Cancer 37:1166-1172(2001).
//